相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prospective Study of Self-Reported Diabetes and Risk of Upper Gastrointestinal Cancers
Shih-Wen Lin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
Dorothee Pflueger et al.
GENOME RESEARCH (2011)
Common Gene Rearrangements in Prostate Cancer
Mark A. Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mapping copy number variation by population-scale genome sequencing
Ryan E. Mills et al.
NATURE (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
A Computational Framework Discovers New Copy Number Variants with Functional Importance
Samprit Banerjee et al.
PLOS ONE (2011)
Therapeutic Targeting of SPINK1-Positive Prostate Cancer
Bushra Ateeq et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy
Shu-Pin Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Structural Variation in the Human Genome and its Role in Disease
Pawel Stankiewicz et al.
ANNUAL REVIEW OF MEDICINE (2010)
E17K substitution in AKT1 in prostate cancer
J. L. Boormans et al.
BRITISH JOURNAL OF CANCER (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer
Sunita R. Setlur et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
Iona Cheng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
Nuria Coll Bastus et al.
CANCER RESEARCH (2010)
Susceptibility Loci Associated with Prostate Cancer Progression and Mortality
David J. Gallagher et al.
CLINICAL CANCER RESEARCH (2010)
Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Origins and functional impact of copy number variation in the human genome
Donald F. Conrad et al.
NATURE (2010)
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan et al.
NATURE (2010)
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Michael C. Haffner et al.
NATURE GENETICS (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
Ram-Shankar Mani et al.
NATURE REVIEWS GENETICS (2010)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer
Jianfeng Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CYP17 Polymorphisms and Prostate Cancer Outcomes
Jonathan L. Wright et al.
PROSTATE (2010)
Vitamin D Pathway Gene Variants and Prostate Cancer Prognosis
Sarah K. Holt et al.
PROSTATE (2010)
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
B. Furusato et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
Andrea Sboner et al.
GENOME BIOLOGY (2010)
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Kyung Park et al.
NEOPLASIA (2010)
Copy Number Variation in Human Health, Disease, and Evolution
Feng Zhang et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS (2009)
TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
Kari Rostad et al.
APMIS (2009)
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
J. Nilsson et al.
BRITISH JOURNAL OF CANCER (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
Chunru Lin et al.
CELL (2009)
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2009)
Distinct Genomic Aberrations Associated with ERG Rearranged Prostate Cancer
Francesca Demichelis et al.
GENES CHROMOSOMES & CANCER (2009)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Bo Han et al.
MODERN PATHOLOGY (2009)
Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
Min Zhuang et al.
MOLECULAR CELL (2009)
Transcriptome sequencing to detect gene fusions in cancer
Christopher A. Maher et al.
NATURE (2009)
Implications of chimaeric non-co-linear transcripts
Thomas R. Gingeras
NATURE (2009)
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J. Diskin et al.
NATURE (2009)
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Rosalind A. Eeles et al.
NATURE GENETICS (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers
Harri Makkonen et al.
NUCLEIC ACIDS RESEARCH (2009)
Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Ram-Shankar Mani et al.
SCIENCE (2009)
Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets
Bora Gurel et al.
ADVANCES IN ANATOMIC PATHOLOGY (2008)
The Hsp90 molecular chaperone: an open and shut case for treatment
Laurence H. Pearl et al.
BIOCHEMICAL JOURNAL (2008)
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
Robert L. Grubb et al.
BJU INTERNATIONAL (2008)
Tyrol Prostate Cancer Demonstration Project: Early detection, treatment, outcome, incidence and mortality
Georg Bartsch et al.
BJU INTERNATIONAL (2008)
Use of the prostate-specific antigen test among US men: Findings from the 2005 national health interview survey
Louie E. Ross et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
M. Scott Lucia et al.
CANCER PREVENTION RESEARCH (2008)
Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Karin G. Hermans et al.
CANCER RESEARCH (2008)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
Association of Megalin genetic polymorphisms with prostate cancer risk and prognosis
Sarah K. Holt et al.
CLINICAL CANCER RESEARCH (2008)
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
Jussi P. Koivunen et al.
CLINICAL CANCER RESEARCH (2008)
The current excitement about copy-number variation: how it relates to gene duplications and protein families
Jan O. Korbel et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)
Rapid whole-genome mutational profiling using next-generation sequencing technologies
Douglas R. Smith et al.
GENOME RESEARCH (2008)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
PCA3: A molecular urine assay for predicting prostate biopsy outcome
Ina L. Deras et al.
JOURNAL OF UROLOGY (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Accurate whole human genome sequencing using reversible terminator chemistry
David R. Bentley et al.
NATURE (2008)
Multiple loci identified in a genome-wide association study of prostate cancer
Gilles Thomas et al.
NATURE GENETICS (2008)
Multiple newly identified loci associated with prostate cancer susceptibility
Rosalind A. Eeles et al.
NATURE GENETICS (2008)
Integrated detection and population-genetic analysis of SNPs and copy number variation
Steven A. McCarroll et al.
NATURE GENETICS (2008)
Cumulative association of five genetic variants with prostate cancer
S. Lilly Zheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome
Adam Shlien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The UGT2B17 gene deletion is not associated with prostate cancer risk
Mats Olsson et al.
PROSTATE (2008)
Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate
A-H Karypidis et al.
PHARMACOGENOMICS JOURNAL (2008)
The ADAMs: signalling scissors in the tumour microenvironment
Gillian Murphy
NATURE REVIEWS CANCER (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB21P
David Duggan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
Jacques Lapointe et al.
CANCER RESEARCH (2007)
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
Daphne Hessels et al.
CLINICAL CANCER RESEARCH (2007)
Assessing individual risk for prostate cancer
Robert K. Nam et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Relative impact of nucleotide and copy number variation on gene expression phenotypes
Barbara E. Stranger et al.
SCIENCE (2007)
The UGT2B17 gene deletion polymorphism and risk of prostate cancer - A case-control study in Caucasians
Carla J. Gallagher et al.
CANCER DETECTION AND PREVENTION (2007)
Global variation in copy number in the human genome
Richard Redon et al.
NATURE (2006)
A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer
C. Cybulski et al.
JOURNAL OF MEDICAL GENETICS (2006)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Matthew L. Freedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men
Jong Park et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Copy number variation: New insights in genome diversity
Jennifer L. Freeman et al.
GENOME RESEARCH (2006)
A topoisomerase IIβ-mediated dsDNA break required for regulated transcription
BG Ju et al.
SCIENCE (2006)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
A common variant associated with prostate cancer in European and African populations
Laufey T. Amundadottir et al.
NATURE GENETICS (2006)
Assessing prostate cancer risk: Results from the prostate cancer prevention trial
IM Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Structural variants: changing the landscape of chromosomes and design of disease studies
L Feuk et al.
HUMAN MOLECULAR GENETICS (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Accurate multiplex polony sequencing of an evolved bacterial genome
J Shendure et al.
SCIENCE (2005)
Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase
I Hernádez-Muñoz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Human tMDC III: a sperm protein with a potential role in oocyte recognition
J Frayne et al.
MOLECULAR HUMAN REPRODUCTION (2002)
Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex
F Vazquez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2
XY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
